Real-time enrollment status for this b-cell acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT04546399 |
| Recruiting Status | Recruiting |
| Condition | B-Cell Acute Lymphoblastic Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 461 participants |
| Active Locations | 202 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | September 10, 2025 (Sep 10, 2025) |
As of March 2, 2026: Clinical trial NCT04546399 is currently recruiting participants. This clinical trial study for b-cell acute lymphoblastic leukemia is actively seeking new participants at 202 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04546399 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 202 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04546399 was last updated Sep 10, 2025 (September 10, 2025). HelloStudys verifies this status automatically.